Evidence To Practice
Clinical Practice Guidelines DB
- Clinical Practice Guidelines
- Introduction of CPGs
- KMCPG Recommendation System
KMCPG Recommendation System
KMCPG Recommendation System
- Recommendations for KMCPGs are divided into evidence-based recommendations and consensus-based recommendations.
- Evidence-based recommendations: recommendations developed based on clinical research results using modern research methodology
- Consensus-based recommendations: recommendations developed by the expert group's official agreement, even though clinical research has not yet been conducted.
Level of evidence
The level of evidence refers to the degree to which confidence in the effectiveness of the intervention is based on evidence. In Korean medicine, CPGs basically follow the GRADE methodology (which applies to evidence-based recommendations).
| Level of evidence | Definition |
|---|---|
| High | We are very confident that the true effect lies is close to the estimated effect. |
| Moderate | We are moderately confident in the effect estimate: The true effect is likely to be close to the estimated effect, but it may be substantially different. |
| Low | Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimated effect. |
| Very Low | We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimated effect. |
Strength of recommendation
The strength of the recommendation refers to the degree of certainty that the benefit will be greater than or less than the harm when the intervention is conducted. The strength of the recommendation is determined by carefully weighing the intervention’s benefits and risks, the level of evidence, the use of clinical practice, cost, value, and patient preference.
Strength of recommendation (Evidence-based)
| Strength of recommendation | Definition | Notation |
|---|---|---|
| A | Considering the benefits and harms, the level of evidence, and the level of use in clinical settings, it is strongly recommended in almost all clinical situations. | Is recommended |
| B | Considering the benefits and harms, the level of evidence, and the level of use in clinical settings, it should be considered in most clinical situations. | Should be considered |
| C | Considering the benefits and harms, the level of evidence, and the level of use in clinical settings, it may be considered in some clinical situations. | May be considered |
| D | Considering the benefits and harms, the level of evidence, and the level of use in clinical settings, it is not recommended in most clinical situations. | Is not recommended |
| Inconclusive | No recommendation is made because consensus could not be reached, although various pieces of evidence and opinions were reviewed and discussed. | Is inconclusive |
Strength of recommendation (Consensus-based)
| Strength of recommendation | Definition | Notation |
|---|---|---|
| Good Practice Point (GPP) | It is recommended based on the formal consensus of the expert group. Is recommended based on the formal consensus of the expert group. | It is recommended based on the formal consensus of the expert group. Is recommended based on the formal consensus of the expert group. |
| Inconclusive | No recommendation is made because consensus could not be reached, although various pieces of evidence and opinions were reviewed and discussed. | Is inconclusive |